Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials
Michał Marczyk, Anna Mrukwa, Christina Yau, Denise M. Wolf, Y.-Y. Chen, Ronald Balassanian, Rita Nanda, Barbara A. Parker, Gregor Krings, Husain Sattar, Jay Zeck, Kathy S. Albain, Judy C. Boughey, M.C. Liu, Anthony Elias, Amy S. Clark, Sara J. Venters, Sonal Shad, Amrita Basu, Smita Asare, Meredith Buxton, Adam L. Asare, Hope S. Rugo, Jane Perlmutter, Angela DeMichele, Douglas Yee, Donald A. Berry, Laura Van't Veer, W. Fraser Symmans, Laura J. Esserman, Lajos Pusztai
Topics & Concepts
MedicineBreast cancerRandomized controlled trialOncologyCancerChemotherapyNeoadjuvant therapyInternal medicineMetric (unit)Operations managementEconomicsBreast Cancer Treatment StudiesGlobal Cancer Incidence and ScreeningCancer Risks and Factors